{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:44:18Z","timestamp":1789753458571,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pnpbp.2024.111191","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T13:01:38Z","timestamp":1731070898000},"page":"111191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A new pharmacological strategy against treatment-resistant depression"],"prefix":"10.1016","volume":"136","author":[{"given":"Juan Pedro","family":"Pineda-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Mill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Cantero-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Flores-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Ladr\u00f3n","family":"de Guevara-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Flores-Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaida","family":"D\u00edaz-Cabiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111191_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2019.07.007","article-title":"Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response","volume":"105","author":"Aleksandrova","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111191_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.euroneuro.2017.10.032","article-title":"Can we increase speed and efficacy of antidepressant treatments? Part I: general aspects and monoamine-based strategies","volume":"28","author":"Artigas","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"28","key":"10.1016\/j.pnpbp.2024.111191_bb0015","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1073\/pnas.0403802101","article-title":"Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests","volume":"101","author":"Bartfai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111191_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbrc.2014.08.061","article-title":"Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex","volume":"452","author":"Borroto-Escuela","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111191_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23061341","article-title":"Receptor\u2212receptor interactions in multiple 5-HT1A heteroreceptor complexes in raphe-hippocampal 5-HT transmission and their relevance for depression and its treatment","volume":"23","author":"Borroto-Escuela","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111191_bb0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-6147(00)01446-2","article-title":"Galanin receptor subtypes","volume":"21","author":"Branchek","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111191_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2215-0366(16)30024-4","article-title":"Scaling-up treatment of depression and anxiety: a global return on investment analysis","volume":"3","author":"Chisholm","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111191_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2004.06.052","article-title":"A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression","volume":"1021","author":"De La Garza","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111191_bb0050","first-page":"113","article-title":"Neurochemical modulation of central cardiovascular control: the integrative role of galanin","volume":"102","author":"D\u00edaz-Cabiale","year":"2010","journal-title":"Exp. Suppl."},{"key":"10.1016\/j.pnpbp.2024.111191_bb0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbr.2012.10.025","article-title":"Appetitive and consummative responding for liquid sucrose in the spontaneously hypertensive rat model of attention deficit hyperactivity disorder","volume":"238","author":"Dommett","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111191_bb0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0028-3908(99)00009-X","article-title":"Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats","volume":"38","author":"Durand","year":"1999","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2024.111191_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jad.2008.10.014","article-title":"What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies","volume":"116","author":"Fekadu","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111191_bb0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuropharm.2017.03.010","article-title":"Galanin (1-15) enhancement of the behavioral effects of fluoxetine in the forced swimming test gives a new therapeutic strategy against depression","volume":"118","author":"Flores-Burgess","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111191_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuropharm.2019.05.023","article-title":"Galanin (1-15)-fluoxetine interaction in the novel object recognition test. Involvement of 5-HT1A receptors in the prefrontal cortex of the rats","volume":"155","author":"Flores-Burgess","year":"2019","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111191_bb0090","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ijnp\/pyab089","article-title":"Galanin(1-15) enhances the behavioral effects of fluoxetine in the olfatory bulbectomy rat suggesting a new augmentation strategy","volume":"25","author":"Flores-Burgess","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111191_bb0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ijnp\/pyab089","article-title":"Galanin (1-15) enhances the behavioral effects of fluoxetine in the olfactory bulbectomy rat, suggesting a new augmentation strategy in depression","volume":"25","author":"Flores-Burgess","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111191_bb0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.brainresrev.2007.11.007","article-title":"Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology","volume":"58","author":"Fuxe","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pnpbp.2024.111191_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fendo.2012.00127","article-title":"On the existence and function of galanin receptor heteromers in the central nervous system","volume":"3","author":"Fuxe","year":"2012","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"19","key":"10.1016\/j.pnpbp.2024.111191_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910848","article-title":"Galanin(1-15) potentiates the antidepressant-like effects induced by escitalopram in a rat model of depression","volume":"22","author":"Garc\u00eda-Dur\u00e1n","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111191_bb0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.0007-1331.2001.00752.x","article-title":"Decreased corticotropin-releasing factor receptor expression and adrenocorticotropic hormone responsiveness in anterior pituitary cells of Wistar-Kyoto rats","volume":"14","author":"Hauger","year":"2002","journal-title":"J. Neuroendocrinol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111191_bb0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0893-133X(01)00351-7","article-title":"Vasopressin mediates the response of the combined dexamethasone\/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders","volume":"26","author":"Keck","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111191_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","article-title":"The epidemiology of depression across cultures","volume":"34","author":"Kessler","year":"2013","journal-title":"Annu. Rev. Public Health"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111191_bb0135","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00018-008-8160-9","article-title":"Galanin, galanin receptor subtypes and depression-like behaviour","volume":"65","author":"Kuteeva","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111191_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2007.05.009","article-title":"The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease","volume":"115","author":"Lang","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111191_bb0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0893-133X(99)00100-1","article-title":"Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test","volume":"22","author":"L\u00f3pez-Rubalcava","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111191_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.npep.2004.12.012","article-title":"Galanin receptor ligands","volume":"39","author":"Lu","year":"2005","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111191_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.04.023","article-title":"Reward and anxiety in genetic animal models of childhood depression","volume":"164","author":"Malkesman","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111191_bb0165","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/mol.106.022756","article-title":"Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain","volume":"70","author":"Mannoury la Cour","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111191_bb0170","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2020.02.023","article-title":"The identification, assessment and management of difficult-to-treat depression: an international consensus statement","volume":"267","author":"McAllister-Williams","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111191_bb0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S2215-0366(20)30516-2","article-title":"Reconceptualising treatment-resistant depression as difficult-to-treat depression","volume":"8","author":"McAllister-Williams","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111191_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109908","article-title":"The Wistar-Kyoto rat model of endogenous depression: a tool for exploring treatment resistance with an urgent need to focus on sex differences","volume":"101","author":"Millard","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111191_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu064","article-title":"A role for galanin N-terminal fragment (1-15) in anxiety- and depression-related behaviors in rats","volume":"18","author":"Mill\u00f3n","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111191_bb0190","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1007\/s00429-015-1180-y","article-title":"Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system","volume":"221","author":"Mill\u00f3n","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.pnpbp.2024.111191_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.npep.2017.01.004","article-title":"The neuropeptides Galanin and Galanin(1-15) in depression-like behaviours","volume":"64","author":"Mill\u00f3n","year":"2017","journal-title":"Neuropeptides"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111191_bb0200","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/0269881119844188","article-title":"Role of the galanin N-terminal fragment (1-15) in anhedonia: involvement of the dopaminergic mesolimbic system","volume":"33","author":"Mill\u00f3n","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111191_bb0205","first-page":"7","article-title":"Galanin, galanin receptors, and drug targets","volume":"102","author":"Mitsukawa","year":"2010","journal-title":"Exp. Suppl."},{"issue":"2 Pt 2","key":"10.1016\/j.pnpbp.2024.111191_bb0210","first-page":"R353","article-title":"Strain differences in hypothalamic-pituitary-adrenal activity and stress ulcer","volume":"266","author":"Redei","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111191_bb0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbr.2007.08.013","article-title":"Strain differences in anxiety-like behavior: association with corticotropin-releasing factor","volume":"186","author":"Shepard","year":"2008","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111191_bb0220","doi-asserted-by":"crossref","first-page":"R786","DOI":"10.1152\/ajpregu.2001.281.3.R786","article-title":"Altered hormone levels and circadian rhythm of activity in the WKY rat, a putative animal model of depression","volume":"281","author":"Solberg","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111191_bb0225","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.psyneuen.2007.03.012","article-title":"Plasma corticosterone, dexamethasone (DEX) suppression and DEX\/CRH tests in a rat model of genetic vulnerability to depression","volume":"32","author":"Steimer","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111191_bb0230","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111191_bb0235","doi-asserted-by":"crossref","first-page":"377","DOI":"10.31887\/DCNS.2008.10.4\/mhtrivedi","article-title":"Treatment strategies to improve and sustain remission in major depressive disorder","volume":"10","author":"Trivedi","year":"2008","journal-title":"Dialogues Clin. Neurosci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:27:28Z","timestamp":1745854048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624002598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"alternative-id":["S0278584624002598"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111191","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new pharmacological strategy against treatment-resistant depression","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111191"}}